The future of continuous blood glucose monitoring is now
The future of continuous blood glucose monitoring is now
Sustainable
We combine precision, sustainability, and reusable components: our sensor is designed to last up to four weeks, minimizing waste and lowering costs.
Precise
This new sensor precisely and continuously measures the glucose concentration in the tissue fluid under the skin in diabetics.
Innovative
The innovative technology employs an optical sensor to enable painless, continuous glucose monitoring by detecting a specific biomarker within a hydrogel.
User-friendly
Our system allows for discreet, wireless real-time monitoring of glucose levels, with instant alerts for any fluctuations.
Advanced technology forprecise and continuous monitoring.
EyeSense technology is transforming blood glucose measurement with its cutting-edge fiber optic sensor, which provides precise, continuous monitoring of glucose concentration in the tissue fluid beneath the skin. Central to this breakthrough is a specialized biosensor embedded in a water-based hydrogel that reacts specifically to glucose, ensuring accurate and responsive readings.
Precision meets innovation:the future of blood glucose monitoring
Precision meets innovation:the future of blood glucose monitoring
EyeSense is redefining diabetes management for both type 1 and type 2 patients with a groundbreaking platform that combines reliability, discretion, durability, and sustainability. The sensor’s four-week wearability significantly reduces both costs and environmental impact. Future software updates will expand its capabilities, allowing the system to adapt flexibly to user needs. With advanced technology and promising clinical outcomes, EyeSense stands as the leading solution for accurate, safe, and convenient blood glucose monitoring.
The FiberSense platform:More than just blood glucose monitoring
FiberSense technology lays the foundation for a groundbreaking platform that extends well beyond blood glucose monitoring. EyeSense’s innovative approach holds the potential to capture a broad spectrum of biometric data in the future, including ketones, lactate, cortisol and other important biomarkers and hormones. This adaptability makes EyeSense a versatile health companion, evolving to meet users’ needs. With software update capabilities, the technology remains at the cutting edge, advancing personalized medicine and ensuring you’re prepared for the future.
EyeSense: Innovation and experiencemedical technology for tomorrow
Since 2006, EyeSense has been a leader in medical technology innovation. Originating as a spin-off from CIBA Vision (Alcon), formerly part of the Novartis Group, we bring together decades of expertise with cutting-edge technologies to enhance the quality of life for those with chronic conditions. Our mission focuses on developing an accurate and reliable continuous glucose monitoring system that simplifies daily life and advances the future of health monitoring. With a clear vision, deep technical expertise, and a commitment to sustainability, we are setting new standards in diabetes care. Join us in our journey to redefine medical technology.
More control, more freedom
The EyeSense app puts effortless health management at your fingertips. Our continuous glucose monitoring operates seamlessly in the background, letting you focus on enjoying daily life with peace of mind. Glucose levels are transmitted to your smartphone in real time, providing you with a clear view of your health at any moment. If something is amiss, the app instantly alerts you—ensuring you feel safe and supported. EyeSense is your trusted companion, offering freedom and security so you can focus on what truly matters: living your life.
More quality of life starts hereDiscover EyeSense now.
Please contact us for more information.